Progress of Gut Microbiota in the Antineoplastic Efficacy of Chemotherapeutic Drugs
- VernacularTitle: 肠道菌群对化疗药物抗肿瘤疗效的影响及其研究进展
- Author:
Wen-Bing MA
1
Author Information
- Publication Type:Journal Article
- Keywords: Chemotherapeutic drug; Effectiveness; Gut microbiota; Immunotherapy; Tumor growth
- From: Chinese Pharmaceutical Journal 2020;55(12):979-984
- CountryChina
- Language:Chinese
- Abstract: Chemotherapeutic drugs play an important role in the treatment of cancer, but the individual differences of patients' sensitivity to chemotherapeutic drugs and the drug resistance of chemotherapeutic drugs have always been a thorny problem in clinical treatment. Recent studies have shown that gut microbiota plays a key role in regulating the efficacy of chemotherapeutic drugs. Gut microbiota can regulate host response to chemotherapy through a variety of mechanisms, including immune interaction, heterogeneous metabolism and changes in community structure. This paper introduces the effects of traditional chemotherapeutic drugs and new immunotherapeutic drugs, such as anti-CTLA-4 and anti-PD-1 antibodies, on gut microbiota, as well as their effects on chemotherapeutic efficacy and mechanism, in order to provide evidences and clues for cancer treatments targeting gut microbiota.
